Advanced Oncotherapy Plc (AVO)

London
38.00
0.00(0.00%)
  • Volume:
    338,381
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    38.00 - 38.00

AVO Overview

Prev. Close
38
Day's Range
38-38
Revenue
-
Open
38
52 wk Range
28-50
EPS
-0.08
Volume
338,381
Market Cap
171.24M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
317,697
P/E Ratio
-
Beta
1.54
1-Year Change
5.56%
Shares Outstanding
450,634,776
Next Earnings Date
27 Jun 2022
What is your sentiment on Advanced Oncotherapy Plc?
or
Market is currently closed. Voting is open during market hours.

Advanced Oncotherapy Plc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellNeutralBuyNeutral
Technical IndicatorsSellSellStrong SellStrong BuyNeutral
SummarySellSellSellStrong BuyNeutral

Advanced Oncotherapy Plc Company Profile

Advanced Oncotherapy Plc Company Profile

Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device. The Company's segments include Development of Proton Therapy-UK; Development of Proton Therapy-Switzerland; Development of Proton Therapy-USA, and Healthcare-related properties-UK. Its LIGHT system integrates a series of modular linear accelerators. This feature offers hospitals and centers to customize treatment plans based on a range of energies. The Company's Research and development/ADAM S.A. (R&D/ADAM) facility is located on the campus of European Council for Nuclear Research (CERN), Geneva and Switzerland. The Company’s verification and validation site is located in Daresbury, United Kingdom.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.